Mankind Pharma shares rise 2% on robust Q4 results
The newly listed pharma company reported 52% growth in profit at ₹294 crore, while revenue from operations rose 19% to ₹2,053 crore in Q4FY23.
mankind pharma
May 2023
April 2023
March 2023
December 2022
Mankind Pharma shares nosedive 5% on report of I-T raid
The pharma stock, which made its market debut on May 9, has fallen as much as 9% in the last two sessions.
Mankind Pharma shares plunge 7% on day 2 after strong debut
Despite today’s fall, Mankind Pharma shares trade 23.5% higher than its initial public offering (IPO) price of ₹1,080 per share
Mankind Pharma makes stellar debut; lists at 20% premium
The Delhi-based healthcare company raised ₹4,326 crore in the country’s biggest IPO so far this year, which was subscribed 15.32 times on the back of strong response from QIBs.
Despite muted response from retail investors, Mankind Pharma IPO subscribed 15 times
The portion reserved for QIBs was subscribed over 49 times, while quota for NIIs and retail investors were booked 3.8% times and 0.9 times, respectively.
Mankind Pharma IPO opens today; raises ₹1,298 cr from anchor investors
The pharma company has raised ₹1,297.90 crore by allotting 1.2 crore equity shares at upper end of price band at ₹1,080 per share to 77 anchor investors.
Mankind Pharma sets price band for ₹4,326 cr IPO at ₹1026-1080 per share
The IPO of the pharma company will open for subscription on April 25 and close on April 27.
Mankind Pharma to launch IPO this month; looks to raise around ₹4,700 cr
The IPO of the country’s fourth largest pharma company by domestic sales comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.
Panacea Biotec: Making The Vaccine Shift
The company divested its pharma portfolio in India to fund a new thrust in vaccines against pandemic outbreaks.
What’s behind Indian pharma cos’ global acquisition spree
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
